Penn Mutual Asset Management, LLC Kymera Therapeutics, Inc. Transaction History

Penn Mutual Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 26, 2021	SELL	$31.08 - $51.95 $942,563 - $1.58 Million	-30,327 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$35.64 - $85.46 $1.08 Million - $2.59 Million	30,327 New	30,327 $1.18 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.15B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Penn Mutual Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Mutual Asset Management, LLC with notifications on news.